Found 42 results in Expert Content

Summary: This executive summary explores the rationale for intranasal drug delivery and the key intranasal drug product formulation design and optimization considerations that can help ensure safe and effective product performance and manufacturability.​

Listen to this webinar to hear experts share insights into developing intranasal vaccine analytical tools, how to improve the speed and quality of critical batch release and characterization assays and the importance of device selection in determining product performance.

The aim of this study was to verify if the GastroPlus® PBPK software can be used to predict intranasal absorption by comparing predictions with human intranasal pharmacokinetic data from the literature.

Watch this webinar to gain insights into current market trends in dry powders for inhalation, the key capsule characteristics that determine performance and the fundamental physical characteristics of spray-dried and lactose-based powders that contribute to the efficiency of the encapsulation process.

Summary: In this Q&A article, experts discuss intranasal drug product development, in particular best practices and key considerations, from formulation design to manufacture and scale-up.

Summary: In this Q&A article, Catalent experts Carolyn Berg and Carla Vozone discuss innovations in orally inhaled drug products, in particular dry powders for inhalation.

Intranasal delivery is emerging as an alternative route of systemic drug delivery for a variety of indications such as migraine, seizures, breakthrough pain and opioid overdose and more.

Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...

Catalent’s Carla Vozone discusses the significant inhalation trends including those in larger molecules and novel indications.

Explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung regions.